CFDE Data Portal | Search NOP56P2

	Label	Description
	NOP56P2 associations Collection (Entity type)	Associations for NOP56P2_associations
	NOP56P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NOP56P2 Gene (Entity type)	ENSG00000226626 - NOP56 ribonucleoprotein pseudogene 2
	GSE173577 MEK inhibition DK1 [Tursiops] 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195568 palbociclib 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE80819 GSK-343 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE164505 GSE164506 indisulam 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 7 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213291 GSE213294 GSK-J4 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GPR63 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

NOP56P2 associations

Associations for NOP56P2_associations

NOP56P2 associations.tsv

A file from IDG as part of the Harmonizome project

NOP56P2

ENSG00000226626 - NOP56 ribonucleoprotein pseudogene 2

GSE173577 MEK inhibition DK1 [Tursiops] 2 v 1 human dn

A Gene Set from LINCS

GSE195568 palbociclib 2 v 4 human dn

A Gene Set from LINCS

GSE80819 GSK-343 0 v 1 human up

A Gene Set from LINCS

GSE164505 GSE164506 indisulam 3 v 1 human up

A Gene Set from LINCS

GSE176008 pyridoxine 7 v 5 human up

A Gene Set from LINCS

GSE213291 GSE213294 GSK-J4 0 v 3 human dn

A Gene Set from LINCS

GPR63 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.